$RJF

Investment Banking & Brokerage Stocks Q2 Recap: Benchmarking Raymond James (NYSE:RJF)

A Q2 recap of 15 investment banking and brokerage stocks says the group’s revenues beat analysts’ consensus by 4.5%, while next-quarter guidance was 1.1% below. Raymond James (RJF) reported $3.93B revenue (+15.6% YoY), beating by 1.4%. Houlihan Lokey (HLI) reported $511M revenue (-15.6%), missing by 16.3%.

Original reporting
Published Aug 18, 2026, 3:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 2:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Investment Banking & Brokerage Stocks Q2 Recap: Benchmarking Raymond James (NYSE:RJF) — source image
Decision brief

The 30-second read

$RJFBullishLow
01

Why it matters

The only concrete, decision-relevant inputs are the reported Q2 revenue/EPS beats or misses and the described post-report stock moves. However, the article repeatedly notes prices have been relatively unchanged since results, suggesting limited incremental trading edge.

02

Market read

Earnings beats and misses are quantified for several brokerages, but the article provides no new forward catalyst beyond a generic sector guidance delta.

03

What to watch

The piece lacks segment-level drivers (IB vs wealth vs trading), deal pipeline commentary, and specific next-quarter guidance for each firm, which likely explains why some stocks moved opposite to the headline beats.

Relevance 4/10Novelty 3/10Timing: after Q2 earnings results, with stocks described as steady since reporting

Background

A multi-stock Q2 recap for the investment banking and brokerage industry, highlighting which names beat or missed analyst estimates.

Company-level read

Ticker impact

$RJFBullishMedium confidence
Context

Raymond James reported Q2 revenue of $3.93B, up 15.6% YoY, beating analysts by 1.4% and EPS estimates.

Expected impact

Near-term upside likely capped unless next-quarter guidance or deal-flow trends re-accelerate.

Evidence & confidence

The text provides a concrete earnings beat and notes the stock is up 6.8% since reporting, but also says prices have held steady on average, implying limited fresh repricing.

$PWPBullishMedium confidence
Context

Perella Weinberg posted Q2 revenue of $156.5M, flat YoY, yet beat analysts by 8.1% and topped EPS expectations.

Expected impact

Moderate support for momentum, with follow-through dependent on subsequent quarters not discussed here.

Evidence & confidence

The article includes specific revenue and EPS beat figures and notes the stock is up 12.5% since reporting, but it is still a recap of already-reported results.

$HLIBearishMedium confidence
Context

Houlihan Lokey reported Q2 revenue of $511M, down 15.6% YoY, missing analysts by 16.3% and also missing EPS/EBITDA.

Expected impact

Further downside is possible if the miss signals weaker deal-cycle conditions, but the article provides no new forward catalyst.

Evidence & confidence

Concrete miss metrics are provided and the stock reaction is described, yet the piece lacks new post-earnings developments or guidance details.

$BGCNeutralLow confidence
Context

BGC reported Q2 revenue of $812.7M, up 8.3% YoY, in line with expectations, while EPS beat and the stock fell 5.2% since reporting.

Expected impact

Range-bound to slightly negative until more detail emerges on trading/fee drivers.

Evidence & confidence

The article gives revenue in-line and EPS beat, but the stock decline implies other factors; without those specifics, directional inference is weak.

$MCBullishMedium confidence
Context

Moelis reported Q2 revenue of $409.4M, up 12% YoY, beating analysts by 5.6%, and the stock is up 2.3% since reporting.

Expected impact

Mildly positive bias, with follow-through dependent on next-quarter performance not detailed here.

Evidence & confidence

The text includes specific beat figures and a modest post-report stock gain, but it also frames the broader group as relatively unchanged.

Market effects

Sector-level framing says group revenues beat consensus by 4.5% while next-quarter guidance is 1.1% below, implying mild caution on forward growth.

Primarily US-listed investment bank/brokerage earnings read-through, no specific regional shock described.

No explicit global macro or cross-border regulatory event is disclosed beyond generic sector headwinds.

Counterpoint

Because the article says shares have held steady on average since earnings, the market may already be pricing the results, making the “best/worst” framing less actionable.

Key entities

  • Raymond James Financial

    Q2 revenue $3.93B (+15.6% YoY) beat by 1.4%, with EPS beat and stock up 6.8% since reporting.

  • Perella Weinberg Partners

    Q2 revenue $156.5M flat YoY but beat by 8.1%, with EPS beat and stock up 12.5% since reporting.

  • Houlihan Lokey

    Q2 revenue $511M down 15.6% YoY, missed by 16.3%, with EPS and EBITDA misses and stock down 10% since results.

  • BGC Group

    Q2 revenue $812.7M up 8.3% YoY in line with expectations, EPS beat, but stock down 5.2% since reporting.

  • Moelis & Company

    Q2 revenue $409.4M up 12% YoY beat by 5.6%, with EBITDA and EPS beats and stock up 2.3% since reporting.

Related articles

$RJFMed

BofA raises Raymond James stock price target to $198 on higher NII

BofA Securities raised its price target for Raymond James Financial (RJF) to $198 from $196, citing higher expected net interest income. The firm maintained a Neutral rating. RJF's shares trade at $158.21. BofA increased its 2027 and 2028 EPS estimates to $14.95 and $18.00, respectively. RJF reported Q3 2026 adjusted earnings of $3.14 per share, beating expectations, with revenue up 16% YoY. Citizens also raised its price target to $205, maintaining an Outperform rating.

$RJFMed

Wells Fargo Initiates Coverage on Raymond James (RJF) with Equal

Wells Fargo initiated coverage on Raymond James Financial (RJF) with an Equal Weight rating and a $172 price target. RJF is trading at $159.76, slightly above its GF Value of $157.68, indicating a 1.3% overvaluation. The company has a GF Score of 95, reflecting strong financial health. Insiders have sold $30.4 million in shares over the past year. RJF operates in wealth management and financial services, with a market cap of $30.73 billion.

$PIPRMedAI 8/10

Piper Sandler Reportedly In Talks To Acquire Perella Weinberg Partners

Piper Sandler (market cap: $5B) is in talks to acquire Perella Weinberg Partners ($1.4B). The deal would combine their M&A advisory businesses amid a 33% U.S. M&A volume recovery in 2026. Piper Sandler generated $1.9B revenue last year, while Perella Weinberg's revenue declined from $878M in 2024 to $750M in 2025. Shares of Perella Weinberg rose 10%, while Piper Sandler's fell 5% on the news.

$PWPHighAI 8/10

Why Perella Weinberg Partners Stock Skyrocketed Today

Perella Weinberg Partners (PWP) shares rose 12% after The Wall Street Journal reported potential merger talks with Piper Sandler (PIPR). Both firms have histories in financial advisory services. Neither company has confirmed the discussions, and the outcome remains uncertain.

$PWPMed

Perella Weinberg (PWP) Stock Trades Up, Here Is Why

Perella Weinberg Partners (PWP) shares rose 11.9% to $16.38 after reports that Piper Sandler is in talks to acquire the firm, according to Morningstar. The stock is volatile, with a 6.7% year-to-date decline and 32.7% below its 52-week high. Piper Sandler's potential acquisition could offer a takeover premium, but talks may not result in a deal.